224 related articles for article (PubMed ID: 22882862)
1. Gray matter involvement in patients with multiple sclerosis as shown by magnetic resonance imaging.
Rumzan R; Chen X; Li YM
Chin Med J (Engl); 2012 Jul; 125(13):2361-4. PubMed ID: 22882862
[TBL] [Abstract][Full Text] [Related]
2. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
3. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
4. Gray matter pathology in (chronic) MS: modern views on an early observation.
Geurts JJ; Stys PK; Minagar A; Amor S; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):12-20. PubMed ID: 19249061
[TBL] [Abstract][Full Text] [Related]
5. Gray matter involvement in multiple sclerosis.
Pirko I; Lucchinetti CF; Sriram S; Bakshi R
Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
[TBL] [Abstract][Full Text] [Related]
6. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
[TBL] [Abstract][Full Text] [Related]
7. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
8. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
Bagnato F; Ohayon JM; Ehrmantraut M; Chiu AW; Riva M; Ikonomidou VN
Expert Rev Neurother; 2006 Apr; 6(4):599-612. PubMed ID: 16623658
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
Inglese M; Grossman RI; Filippi M
J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of grey matter damage in people with MS.
Filippi M; Valsasina P; Rocca M
Int MS J; 2007 Mar; 14(1):12-21. PubMed ID: 17509248
[TBL] [Abstract][Full Text] [Related]
11. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
Zivadinov R; Minagar A
J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
[TBL] [Abstract][Full Text] [Related]
12. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
[TBL] [Abstract][Full Text] [Related]
13. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis.
Mesaros S; Rovaris M; Pagani E; Pulizzi A; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Martinelli V; Comi G; Filippi M
Arch Neurol; 2008 Sep; 65(9):1223-30. PubMed ID: 18779427
[TBL] [Abstract][Full Text] [Related]
14. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS.
Carone DA; Benedict RH; Dwyer MG; Cookfair DL; Srinivasaraghavan B; Tjoa CW; Zivadinov R
Neuroimage; 2006 Jan; 29(2):505-14. PubMed ID: 16169253
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
[TBL] [Abstract][Full Text] [Related]
16. Fractal dimension analysis of grey matter in multiple sclerosis.
Esteban FJ; Sepulcre J; de Miras JR; Navas J; de Mendizábal NV; Goñi J; Quesada JM; Bejarano B; Villoslada P
J Neurol Sci; 2009 Jul; 282(1-2):67-71. PubMed ID: 19167728
[TBL] [Abstract][Full Text] [Related]
17. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.
Inglese M; Ge Y; Filippi M; Falini A; Grossman RI; Gonen O
Neuroimage; 2004 Apr; 21(4):1825-9. PubMed ID: 15050603
[TBL] [Abstract][Full Text] [Related]
18. Information processing speed, neural efficiency, and working memory performance in multiple sclerosis: differential relationships with structural magnetic resonance imaging.
Covey TJ; Zivadinov R; Shucard JL; Shucard DW
J Clin Exp Neuropsychol; 2011 Dec; 33(10):1129-45. PubMed ID: 22047454
[TBL] [Abstract][Full Text] [Related]
19. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
20. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
